| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298353A1 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/23/2011 | EP2298352A1 Percutaneous absorption enhancer and transdermal preparation using the same |
| 03/23/2011 | EP2298351A2 Therapeutic antimicrobial compositions and methods |
| 03/23/2011 | EP2298347A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| 03/23/2011 | EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 03/23/2011 | EP2298327A1 Anti-tumor agent |
| 03/23/2011 | EP2298314A1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 03/23/2011 | EP2298313A1 Pharmaceutical composition for external application containing prochlorperazine |
| 03/23/2011 | EP2298310A2 Therapeutic inhibitors of vascular smooth muscle cells |
| 03/23/2011 | EP2298302A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 03/23/2011 | EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
| 03/23/2011 | EP2298287A2 Stabilised compositions of factor VII polypeptides |
| 03/23/2011 | EP2298285A2 Method of making particles for use in a pharmaceutical composition |
| 03/23/2011 | EP2298284A2 Mucoadhesive pharmaceutical formulations |
| 03/23/2011 | EP2298283A2 Pharmaceutical formulations comprising cannabinoids |
| 03/23/2011 | EP2298281A1 Infusion and injection solution of Levodopa |
| 03/23/2011 | EP2298280A2 Gel comprising a combination of flurbiprofen and muscle relaxant |
| 03/23/2011 | EP2298279A2 Pharmaceutical compositions for inhalation |
| 03/23/2011 | EP2298276A1 Accelerating agent of calcium absorption |
| 03/23/2011 | EP2298235A1 Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices |
| 03/23/2011 | EP2297182A2 Supercharged proteins for cell penetration |
| 03/23/2011 | EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 03/23/2011 | EP2297172A2 Process for producing nanoparticles |
| 03/23/2011 | EP2297032A1 Controllable synthesis of porous carbon spheres, and electrochemical applications thereof |
| 03/23/2011 | EP2296712A1 Amphiphilic block copolymers for nucleic acid delivery |
| 03/23/2011 | EP2296711A2 Multi-arm amines and uses thereof |
| 03/23/2011 | EP2296710A1 Modified protein excipient for delayed-release tablet |
| 03/23/2011 | EP2296709A2 Modified release niacin formulations |
| 03/23/2011 | EP2296708A2 Polymeric carrier |
| 03/23/2011 | EP2296707A2 Compounds suited as nanocarriers for active agents and their use |
| 03/23/2011 | EP2296696A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 03/23/2011 | EP2296637A1 Chitosan-containing protective composition |
| 03/23/2011 | EP2296631A1 Method for manufacturing medicinal compounds containing dabigatran |
| 03/23/2011 | EP2296629A2 Biocompatible and biodegradable elastomeric polymers |
| 03/23/2011 | EP2296628A2 Process for manufacturing flowable powder drug compositions |
| 03/23/2011 | EP2296627A2 Micelles for intracellular delivery of therapeutic agents |
| 03/23/2011 | EP2296626A1 Azide modified proteins |
| 03/23/2011 | EP2296623A1 Compositions for the treatment of lice |
| 03/23/2011 | EP2015736B1 Spherical or non-sperical microcapsules comprising glp-1 peptides, their production and use |
| 03/23/2011 | EP1912673B1 Process for attaching effector molecules to proteins |
| 03/23/2011 | EP1793862B1 A process for the preparation of a piroxicam: beta-cyclodextrin inclusion compound |
| 03/23/2011 | EP1631305B1 Sincalide formulations |
| 03/23/2011 | EP1515741B1 Use of collagen hydrolysate to lower the viscosity of a composition comprising guar gum |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | EP1446101B1 Catheter injectable depot compositions and uses thereof |
| 03/23/2011 | EP1353647B1 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 03/23/2011 | EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/23/2011 | EP1112739B1 Long time drug-sustained release preparation |
| 03/23/2011 | EP0792166B1 Internalisation of dna, using conjugates of poly-l-lysine and a peptide integrin receptor ligand |
| 03/23/2011 | CN1951372B Solid oral dosage forms comprising valsartan and HCTZ |
| 03/23/2011 | CN101990442A Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 03/23/2011 | CN101990441A Biocompatible biodegradable fumagillin analog conjugates |
| 03/23/2011 | CN101990440A Crosslinking method and crosslinked polysaccharide made thereby |
| 03/23/2011 | CN101990427A Combination of mitiglinide and metformin and process for preparing same |
| 03/23/2011 | CN101990424A Vesicle and cosmetic containing the same |
| 03/23/2011 | CN101987873A P53 fusion protein and application thereof |
| 03/23/2011 | CN101987830A Preparation method and preparation of water-soluble florfenicol succinic acid ester |
| 03/23/2011 | CN101987201A Medical ultrasonic probe sterilizing gel and preparation method thereof |
| 03/23/2011 | CN101987199A Antipyretic and analgesic injection composition |
| 03/23/2011 | CN101987195A Reduced glutathione medicine absorbed through oral mucosa |
| 03/23/2011 | CN101987144A Traditional Chinese medicine composition for preventing and treating animal infectious diseases |
| 03/23/2011 | CN101987142A Active ingredient detection method of traditional Chinese medicine soft capsule |
| 03/23/2011 | CN101987126A Medical burn antipyretic gauze and preparation thereof |
| 03/23/2011 | CN101987109A Ophthalmic composition containing povidone iodine and cyclodextrin included glucocorticoid |
| 03/23/2011 | CN101987099A Omeprazole sodium for injection and preparation method thereof |
| 03/23/2011 | CN101987094A Ornithine aspartate injection and preparation method thereof |
| 03/23/2011 | CN101987093A Ferrous lactate gel skeleton slow-release preparation and preparation method thereof |
| 03/23/2011 | CN101987091A Venlafaxine hydrochloride sustained-release pellet capsules |
| 03/23/2011 | CN101987090A Fluoxetine capsule and preparation method thereof |
| 03/23/2011 | CN101987089A Effervescent medicinal preparation |
| 03/23/2011 | CN101987088A Preparation and applications of paeonol controlled-release preparation |
| 03/23/2011 | CN101987087A Sodium hyaluronate chewable tablet and preparation method thereof |
| 03/23/2011 | CN101987086A Ultra-fine bicalutamide oral tablet and preparation method thereof |
| 03/23/2011 | CN101987085A High-efficiency adhesive powder for treating livestock and poultry diseases |
| 03/23/2011 | CN101987084A Chitosan-collagen sustained-release eye drop and preparation method |
| 03/23/2011 | CN101987083A Preparation method for controlled release preparation, especial for zero-order release controlled release preparation |
| 03/23/2011 | CN101987082A Solid preparation and preparation method thereof |
| 03/23/2011 | CN101987081A Controlled release preparation |
| 03/23/2011 | CN101843621B TS-1 granules and preparation method thereof |
| 03/23/2011 | CN101744762B Preparation method of butenafine hydrochloride liniment |
| 03/23/2011 | CN101647906B Preparation containing henbane and daturaflower for treating cancer pain and surgery wound pain |
| 03/23/2011 | CN101618186B Traditional Chinese medicine prescription for treating arthritis |
| 03/23/2011 | CN101602875B Polyvinyl acetate mixed suspended liquid and preparation method and application thereof |
| 03/23/2011 | CN101601646B Nasal cavity drop for treating diabetes and preparation method thereof |
| 03/23/2011 | CN101543481B Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 03/23/2011 | CN101422431B Insulation administration preparation through nose |
| 03/23/2011 | CN101396437B Anti-gout drop pills of pure traditional Chinese medicine |
| 03/23/2011 | CN101385843B Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| 03/23/2011 | CN101336950B Oral nano raw baizhu colon tablet and preparation method thereof |
| 03/23/2011 | CN101292957B Liposome preparation of teniposide phospholipid complexes and preparing method thereof |
| 03/23/2011 | CN101274099B Method for preparing polymer matrix with transfer function |
| 03/23/2011 | CN101214244B Antibiotic medicament containing amoxicillin nano granule and potassium clavulanate |
| 03/23/2011 | CN101152149B Trigone-leaf dioscorea opposita saponin liposome, method for preparing the same and use of the same |
| 03/23/2011 | CN101112417B Rheum defervescence liniment and method for preparing the same |
| 03/23/2011 | CN101085357B Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof |
| 03/23/2011 | CN101084882B Polyalkylcyanoacrylate nano-capsule and preparation method and application thereof |
| 03/22/2011 | USRE42243 Synthetic viscoelastic material for ophthalmic applications |
| 03/22/2011 | US7910694 Homing peptides to receptors of heart vasculature |
| 03/22/2011 | US7910693 Prostate cancer diagnosis and treatment |